Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using the ReTrieve Automated Stereognosis System to Treat Loss of Tactile Function After Brain Injury

NCT05740553 is registered in ClinicalTrials.gov with The University of Texas at Dallas as lead sponsor.

NCT NCT05740553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05740553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using the ReTrieve Automated Stereognosis System to Treat Loss of Tactile Function After Brain Injury
Lead sponsor
The University of Texas at Dallas
Phase
Not applicable
Overall status
Terminated
Start date
November 15, 2021
Completion date
June 6, 2022
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic brain injury, peripheral neuropathy, stroke